Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592796PMC
http://dx.doi.org/10.1002/mdc3.12770DOI Listing

Publication Analysis

Top Keywords

stereotypy neuroleptic
4
neuroleptic malignant
4
malignant syndrome
4
stereotypy
1
malignant
1
syndrome
1

Similar Publications

Autism spectrum disorder (ASD) is characterized by deficits in communication, social interaction, and repetitive and stereotyped behaviors, with no specific drug therapy available. Studies have found that cannabidiol (CBD) can improve hyperactive and cognitive symptoms in children with ASD. However, little is known about the effect of CBD in combination with other medications, such as risperidone (RISP).

View Article and Find Full Text PDF

The current study examined the antipsychotic properties of ethanolic extracts of Crinum asiaticum (EECA) and Crinum defixum (EECD). The effects of the extracts on rodents' ketamine-induced hyperactivity, amphetamine-induced stereotypy, forced swim test, conditioned avoidance response, and catalepsy were assessed. According to the findings, EECA and EECD both significantly outperformed typical antipsychotic medications in antipsychotic-like behaviours across a variety of behavioural paradigms.

View Article and Find Full Text PDF

Impact of 5-Lipoxygenase Deficiency on Dopamine-Mediated Behavioral Responses.

Neurotox Res

October 2024

Department of Basic and Oral Biology, Ribeirão Preto School of Dentistry, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.

The 5-lipoxygenase/leukotriene system has been implicated in both physiological and pathological states within the central nervous system. Understanding how this system interacts with the dopaminergic system could provide valuable insights into dopamine-related pathologies. This study focused on examining both motor and non-motor dopamine-related responses in 5-lipoxygenase/leukotriene-deficient mice.

View Article and Find Full Text PDF

Effective action of silymarin against ketamine-induced schizophrenia in male mice: Insight into the biochemical and molecular mechanisms of action.

J Psychiatr Res

November 2024

DELSU Joint Canada-Israel Neuroscience and Biopsychiatry Laboratory, Department of Pharmacology, Faculty of Basic Medical Sciences, College of Health Sciences, Delta State University, Abraka, Delta State, Nigeria.

Background: Neurochemical dysregulations resulting from N-methyl-D-aspartate hypofunction (NMDA), are exacerbated by neuroimmune and oxidative stress and are known risk factors for neuropsychiatric disorders like schizophrenia-like diseases. Here, we investigate the protective and curative effects, and mechanisms of silymarin, a polyphenolic flavonoid with neuroprotective functions in preventive-reversal model of ketamine, an NMDA antagonist in mice.

Methods: Mice were grouped into 6 cohorts (n = 9).

View Article and Find Full Text PDF
Article Synopsis
  • Schizophrenia (SZ) is a serious neurodevelopmental disorder primarily treated with antipsychotics, and SEP-363856 is a new antipsychotic currently being studied that doesn't act on dopamine D receptors, but its mechanism is still unclear.
  • The study involved creating an animal model of SZ using perinatal MK-801 treatment combined with social isolation, and various behavioral tests and molecular analyses were performed to assess the effects of SEP-856.
  • Results showed that SEP-856 significantly improved symptoms in the SZ-like model by reducing hyperactivity, enhancing social interaction, and reversing other SZ-associated behaviors.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!